使用血液肝素结合蛋白评估自身免疫性病中中性粒细胞激活:一个试点研究

Zhen-Jun Zhao1, Xin-Yue Shi1,2, Hong-Shan Chen1

  • 1Department of Nephrology, Kidney Disease Medical Center, General Hospital, National Key Clinical Specialty, Tianjin Key Medical Discipline, Tianjin Medical University, Tianjin, China.

Frontiers in medicine
|February 20, 2026
PubMed
概括

血液中肝素结合蛋白 (HBP) 有效地表明在自身免疫性病中中性粒细胞的激活,独立于功能. 升高的HBP水平与疾病活性和蛋白尿相关,这表明它在病变发生过程中的作用.